Navigation Links
Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Date:5/26/2011

ffels.  "The future drivers for success in pharmaceuticals will depend on matching the medical need with the best science and operational excellence.  We have strong therapeutic area expertise to anticipate the medical need and the scientific acumen to access the best science internal or external.

"Our development programs incorporate an outcomes-based approach, embedding customer, physician, and patient insights, while our broad-based expertise and global development operations allow us to deliver competitive products globally, with enhanced productivity and accelerated timelines," Stoffels added.

Joaquin Duato, Worldwide Chairman, Pharmaceuticals, will review the company's growing core pharmaceuticals businesses and key category strength.  Among some of the core growth businesses being discussed today are market-leading immunology medicines, REMICADE®, SIMPONI®, STELARA®, and the long-acting injectable anti-psychotics, RISPERDAL® CONSTA® and INVEGA® SUSTENNA®.  Mr. Duato, Dr. Stoffels and R&D leaders will discuss the company's expectations for new filings and early-stage compounds across the pharmaceuticals business'  five therapeutic areas throughout the day.

"Launch leadership in the United States for 2010 demonstrates not only the strength of our pipeline but our capacity to successfully commercialize important medicines," says Mr. Duato.  "We are leveraging that expertise in key markets around the world, particularly as we launch important global compounds in 2011. I have great confidence in our ability to deliver the promise of our portfolio to make a real difference in patients' lives."  

Full copies of the presentations, as well as a replay and podcast, will be available approximately two hours after the live webcast concludes.  

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the p
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Statistics released from a number of organizations ... during the holidays, beginning with Thanksgiving eve, which is ... The data, highlighted in an Infographic ... of their annual Sober Days for the Holidays ... drinking and increased rates of DUI injuries and deaths ...
(Date:11/21/2014)... Mass. , Nov. 21, 2014  Alere Inc. ... rapid diagnostic tests, has appointed Juliet Cunningham ... role, Cunningham will be responsible for driving communications with ... execute on a series of changes to increase shareholder ... progress to investors," said Namal Nawana, Chief Executive Officer. ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... than 60,000 young children end up in emergency rooms ... or caregivers were not looking. To remind parents and ... Centers for Disease Control and Prevention (CDC) and the ... with the PROTECT Initiative , today launched the ...
... 2011 Sotera Wireless, Inc. today announced the completion ... Singapore-based global fund, EDBI. The round also included new ... Ventures, Intel Capital and West Health Investment Fund. The ... with Cerner, a leading health care technology company, which ...
Cached Medicine Technology:CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 2CDC and CHPA Educational Foundation Launch Up and Away and Out of Sight 3Sotera Wireless Completes $12.2 Million Series D Financing, Signs Agreement with Cerner 2
(Date:11/23/2014)... (PRWEB) November 24, 2014 The ... H2, 2014" provides data on the Aspergillosis clinical ... data relating to the clinical trials on Aspergillosis. ... and their recruitment status as per the site ... offers a preliminary coverage of disease clinical trials ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 23, 2014 ... Energy Devices Market 2006 to 2020 - Asia-Pacific” ... and energy devices market segments: minimally invasive body ... resurfacing devices. The analysis includes market size data ... period for the following countries: China, Japan, South ...
(Date:11/23/2014)... New York, NY (PRWEB) November 23, 2014 ... ) that allege heart attacks, strokes, deep vein ... been filed in a federal multidistrict litigation (MDL) ... Liebhard LLP reports. , Court documents updated ... on Multidistrict Litigation (JPML) show the filing of ...
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... 2014 SWAccessControl.com's high quality access control ... the company has announced its new collection of power ... these high quality power suppliers. All the new models ... special offer lasts until Dec. 20, 2014. , SWAccessControl.com ... have been supporting it for a long time. It ...
Breaking Medicine News(10 mins):Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2
... City Hotel and Casino will host the 3rd ... ReceptionATLANTIC CITY, N.J., Feb. 17 The American ... are teaming up on Wednesday, February 25, 2009 ... Blood Donor Campaign awards reception.(Logo: http://www.newscom.com/cgi-bin/prnh/20090217/DC71647LOGO ...
... Six studies published in the past year by a Cornell ... -- as well as daily helpings of other fruits and ... one of his recent papers, published in the Journal ... Cornell associate professor of food science and a member of ...
... (Feb. 17, 2009) A research project at Rice ... long-standing medical mystery that may link cardiovascular disease, osteoporosis and ... thank the rat. , The recent paper in Artery ... team reports they have found that common rats with a ...
... TORONTO, Feb. 17 /PRNewswire/ - Sentinelle Medical Inc., ... software and Siemens Healthcare today announced an OEM ... agreement, Siemens will sell the "Sentinelle Vanguard for ... Espree, MAGNETOM(R) Avanto and MAGNETOM(R) Symphony, A Tim(TM) ...
... by wartime conditions, researchers say , , TUESDAY, Feb. 17 ... can be exacerbated by combat conditions in Iraq and ... being evacuated for treatment, a new report finds. , ... responsible for poor morale and combat ineffectiveness, the researchers ...
... from The University of Nottingham are taking to the streets ... are nearly twice the national average. , Reducing high levels ... which ranks third highest in the country after Corby and ... Control Studies and Professor in Health Policy and Promotion at ...
Cached Medicine News:Health News:The American Red Cross Recognizes Atlantic City Casinos 2Health News:In flurry of studies, researcher details role of apples in inhibiting breast cancer 2Health News:Mutant rats offer clues to medical mystery 2Health News:Mutant rats offer clues to medical mystery 3Health News:Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG 2Health News:Sentinelle Medical Enters OEM Distribution Agreement with Siemens AG 3Health News:Skin Woes Take Toll on U.S. Combat Troops 2Health News:Skin Woes Take Toll on U.S. Combat Troops 3Health News:Investigating a community where smoking rates are double the national average 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: